Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
RFA-NS-19-001 November 14, 2018; October 18, 2019; June 19, 2020; October 19, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opport unity announcement are due on these dates. October 20, 2020 U01 BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)
PA-18-906 Due dates vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 8, 2021 333 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
RFA-MH-19-135 October 9, 2018; September 26, 2019 and September 28, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 29, 2020 UG3/UH3 BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
RFA-NS-18-041 November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. March 13, 2020 R61/R33 Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
PAR-18-884 December 4, 2018, December 4, 2019, December 4, 2020?, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. December 5, 2020 R01 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
PAR-18-885 December 4, 2018, December 4, 2019, December 4, 2020 ) , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. December 5, 2020 R21 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
PA-18-870 Standard dates apply, by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 7, 2021 R41/R42 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)
PA-18-871 Standard dates apply, by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 7, 2021 R43/R44 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)
RFA-MH-19-147 September 27, 2018; March 7, 2019; September 6, 2019; March 6, 2020; September 9, 2020; March 4, 2021
by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
March 5, 2021 R01 BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
RFA-MH-19-146 September 27, 2018 and September 6, 2019
by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
September 7, 2019 R01 BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
RFA-MH-19-145 September 27, 2018 and September 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 7, 2019 R24 BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
PAR-18-854 August 23, 2018; September 13, 2018; October 10, 2018; November 13, 2018; December 11, 2018; January 10, 2019; February 11, 2019; March 11, 2019; April 11, 2019; May 10, 2019; June 10, 2019; July 11, 2019; August 9, 2019; September 12, 2019; October 11, 2019; November 13, 2019; December 10, 2019; January 10, 2020; February 10, 2020; March 10, 2020; April 7, 2020; May 11, 2020; June 10, 2020; July 10, 2020; August 11, 2020; September 10, 2020; October 14, 2020; November 10, 2020; December 11, 2020; January 11, 2021; February 10, 2021; March 10, 2021; April 9, 2021; May 10, 2021; June 11, 2021; July 9, 2021; August 10, 2021; September 10, 2021 by 5:00 PM local time of applicant organization. September 11, 2021 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
PAR-18-853 November 27, 2018, November 27, 2019, November 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 28, 2020 R61/R33 Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
PA-18-838 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is October 5, 2018.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 8, 2021 R01 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
PA-18-839 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is October 16, 2018.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 8, 2021 R21 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
PAR-18-835 November 7, 2018; November 7, 2019, November 6, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 7, 2020 R01 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
PAR-18-836 November 7, 2018; November 7, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 7, 2020 R21 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
PAR-18-830 November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
June 4, 2021 R01 The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
PAR-18-831 November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020,
June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
June 4, 2021 R21 The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
PAR-18-822 September 4, 2018, September 4, 2019, September 4, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 5, 2020 R01 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
top of pageBACK TO TOP